Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -2.76 is 33% above its 5-year average of -4.11, near the high end of its 5-year range (-17.88–-2.39).
As of the fiscal period ended Tuesday, June 30, 2026. 42.63% above its 12-month average of -4.81.
Reported quarterly debt to equity ratio; no daily interpolation. Q1 FY2027 (2026-06-30): -2.76.
DEBT TO EQUITY RATIO
-2.76
DEBT TO EQUITY RATIO AVG TTM
-4.81
DEBT TO EQUITY RATIO AVG 3Y
-3.90
DEBT TO EQUITY RATIO AVG 5Y
-4.11
DEBT TO EQUITY RATIO AVG 10Y
-1.55
DEBT TO EQUITY RATIO AVG 15Y
-0.72
DEBT TO EQUITY RATIO AVG 20Y
-0.45
CURRENT VS TTM AVG
+42.63%
CURRENT VS 3Y AVG
+29.29%
CURRENT VS 5Y AVG
+32.89%
CURRENT VS 10Y AVG
-77.83%
CURRENT VS 15Y AVG
-283.86%
CURRENT VS 20Y AVG
-516.30%
SECTOR MEDIAN · HEALTHCARE
0.69
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-502.87%
vs the sector median at left
McKesson Corporation
Market Cap
$102.97B
Debt to Equity Ratio
-2.76
TTM Avg
-4.81
3Y Avg
-3.90
5Y Avg
-4.11
Market Cap
$106.18B
Debt to Equity Ratio
0.62
TTM Avg
0.71
3Y Avg
0.74
5Y Avg
0.82
Market Cap
$92.88B
Debt to Equity Ratio
N/A
TTM Avg
57.79
3Y Avg
57.79
5Y Avg
57.79
Market Cap
$88.41B
Debt to Equity Ratio
0.69
TTM Avg
0.78
3Y Avg
0.74
5Y Avg
0.71
Market Cap
$80.93B
Debt to Equity Ratio
0.06
TTM Avg
0.09
3Y Avg
0.10
5Y Avg
0.13
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| McKesson Corporation (MCK) | $102.97B | -2.76 | -4.81 | -3.90 | -4.11 |
| Sanofi (SNY)vs › | $102.10B | 0.34 | 0.26 | 0.26 | 0.29 |
| GSK plc (GSK)vs › | $100.60B | 1.03 | 1.16 | 1.41 | 1.52 |
| Stryker Corporation (SYK)vs › | $106.18B | 0.62 | 0.71 | 0.74 | 0.82 |
| HCA Healthcare, Inc. (HCA)vs › | $92.88B | N/A | 57.79 | 57.79 | 57.79 |
| CVS Health Corp. (CVS)vs › | $113.14B | 0.96 | 1.17 | 1.09 | 1.10 |
| Elevance Health Inc. (ELV)vs › | $88.41B | 0.69 | 0.78 | 0.74 | 0.71 |
| Medtronic plc (MDT)vs › | $118.34B | 0.56 | 0.58 | 0.53 | 0.52 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.93B | 0.06 | 0.09 | 0.10 | 0.13 |
| Bristol-Myers Squibb Company (BMY)vs › | $127.88B | 1.93 | 2.84 | 2.10 | 1.84 |
Debt/Equity
-2.76
Current Ratio
0.89
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -2.76 |
| 2026-03-31 | -3.97 |
| 2025-12-31 | -6.64 |
| 2025-09-30 | -5.63 |
| 2025-06-30 | -5.05 |
| 2025-03-31 | -3.56 |
| 2024-12-31 | -3.16 |
| 2024-09-30 | -2.39 |
| 2024-06-30 | -4.21 |
| 2024-03-31 | -3.75 |
| 2023-12-31 | -3.71 |
| 2023-09-30 | -4.00 |
| 2023-06-30 | -4.63 |
| 2023-03-31 | -3.93 |
| 2022-12-31 | -3.33 |
| 2022-09-30 | -4.08 |
| 2022-06-30 | -3.71 |
| 2022-03-31 | -3.32 |
| 2021-12-31 | -6.29 |
| 2021-09-30 | -13.90 |
| 2021-06-30 | -17.88 |
| 2021-03-31 | -447.86 |
| 2020-12-31 | -19.97 |
| 2020-09-30 | 1.64 |
| 2020-06-30 | 1.73 |
| 2020-03-31 | 1.85 |
| 2019-12-31 | 1.94 |
| 2019-09-30 | 1.59 |
| 2019-06-30 | 1.25 |
| 2019-03-31 | 0.94 |
| 2018-12-31 | 1.07 |
| 2018-09-30 | 0.97 |
| 2018-06-30 | 1.04 |
| 2018-03-31 | 0.80 |
| 2017-12-31 | 0.75 |
| 2017-09-30 | 0.75 |
| 2017-06-30 | 0.70 |
| 2017-03-31 | 0.77 |
| 2016-12-31 | 1.19 |
| 2016-09-30 | 0.86 |
| 2016-06-30 | 0.88 |
| 2016-03-31 | 0.91 |
| 2015-12-31 | 0.98 |
| 2015-09-30 | 1.07 |
| 2015-06-30 | 1.11 |
| 2015-03-31 | 1.23 |
| 2014-12-31 | 1.14 |
| 2014-09-30 | 1.18 |
| 2014-06-30 | 1.19 |
| 2014-03-31 | 1.26 |
| 2013-12-31 | 0.61 |
| 2013-09-30 | 0.61 |
| 2013-06-30 | 0.66 |
| 2013-03-31 | 0.69 |
| 2012-12-31 | 0.59 |
| 2012-09-30 | 0.46 |
| 2012-06-30 | 0.50 |
| 2012-03-31 | 0.58 |
| 2011-12-31 | 0.53 |
| 2011-09-30 | 0.56 |
| 2011-06-30 | 0.58 |
| 2011-03-31 | 0.55 |
| 2010-12-31 | 0.57 |
| 2010-09-30 | 0.33 |
| 2010-06-30 | 0.33 |
| 2010-03-31 | 0.30 |
| 2009-12-31 | 0.35 |
| 2009-09-30 | 0.37 |
| 2009-06-30 | 0.40 |
| 2009-03-31 | 0.41 |
| 2008-12-31 | 0.29 |
| 2008-09-30 | 0.28 |
| 2008-06-30 | 0.29 |
| 2008-03-31 | 0.29 |
| 2007-12-31 | 0.30 |
| 2007-09-30 | 0.31 |
| 2007-06-30 | 0.30 |
| 2007-03-31 | 0.31 |
| 2006-12-31 | 0.16 |
| 2006-09-30 | 0.17 |
| 2006-06-30 | 0.17 |
| 2006-03-31 | 0.17 |
| 2005-12-31 | 0.17 |
| 2005-09-30 | 0.17 |
| 2005-06-30 | 0.17 |
| 2005-03-31 | 0.33 |
| 2004-12-31 | 0.30 |
| 2004-09-30 | 0.27 |
| 2004-06-30 | 0.28 |
| 2004-03-31 | 0.39 |
| 2003-12-31 | 0.34 |
| 2003-09-30 | 0.29 |
| 2003-06-30 | 0.28 |
| 2003-03-31 | 0.29 |
| 2002-12-31 | 0.31 |
| 2002-09-30 | 0.34 |